Osho Aesthetics

Osho Aesthetics Medical Aesthetics/Neuromodulators/Nutritional Injections/Medical Grade Chemical Peels/Dermal Fillers/Skin Tag Removal/Concierge Services & Parties

My hard working national champion! U-17 Women’s quad
10/01/2022

My hard working national champion! U-17 Women’s quad

🔥AMAZING OFFER🔥 Scan code to see if you qualify:::::::::::::::::::::::::::::::::::::::::::::::::: ...
09/21/2022

🔥AMAZING OFFER🔥
Scan code to see if you qualify
::::::::::::::::::::::::::::::::::::::::::::::::::

& 🙌🏻
09/12/2022

& 🙌🏻

09/06/2022

Do you know Jeuveau®? It’s a modern that smooths your 11s (those lines between the brows) in as little as 2 days + up to 4 months*! [Starting 9/1/22,] get $160 off your first two treatments ($80 off 1st & $80 off 2nd) †.

For full Product Information, including Boxed Warning and Medication Guide, see
Facebook: https://evolus.io/piinfo
Instagram:

Jeuveau® (prabotulinumtoxinA-xvfs) injection is an FDA-approved prescription medicine used to temporarily improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults.

Ask your doctor to tell you all about Jeuveau®.

The effects of Jeuveau® may spread hours to weeks after injection causing serious symptoms. Alert your doctor right away as difficulty swallowing, speaking, breathing, eye problems or muscle weakness can be a sign of a life-threatening condition. Side effects may include allergic reactions, injection-site pain, eyelid drooping, and swelling.
Jeuveau® is available by prescription only.

*50% of patients begin showing improvement 2 days after treatment. Most patients (~69%) achieve complete results by 30 days. On average, Jeuveau® patients receive 3 treatments a year.

†Patients eligible once every 90 days. Terms apply.

Address

Portland, OR

Telephone

+15037302330

Website

Alerts

Be the first to know and let us send you an email when Osho Aesthetics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share